Envision Report

Published January 12, 2018

Americas Regenerative Medicines Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Request Free Sample Report!

Regenerative medicine is a branch involved in the repair, replace and regenerate tissues and organs affected due to injury, disease or natural ageing process. These medicines can restore the functionality of cells and tissues and are used in various strategies like cell therapy, gene therapy, and tissue engineering. Many firms and industries are trying to develop and improve the technological approaches to increase the market.

Americas Regenerative Medicines Market Segments size & growth:

The market is valued at USD 17.625 Billion in 2017 and is expected to reach USD 51.453 Billion by 2024 at a CAGR of 23.8%. The primary factors influencing the market growth are growing prevalence of chronic diseases such as bone and joint diseases and trauma emergencies, increasing the need for orthopaedic surgeries, innovation in stem cell therapy, technological innovations and tissue engineering.

Americas Regenerative Medicines Market Segments share:

By application, the market is segmented into orthopaedic, oncology, diabetes, cardiology and central nervous system. Among this oncology is having the most significant share and fastest growth in the market. The market is majorly divided into products, application, therapy, material and agent type. By products, it is segmented into cell-based and acellular, and by therapy, the market is segmented into the cell, therapy, tissue and gene therapy. The application is segmented into orthopaedic, dermatology, cardiology, oncology and central nervous system. By material, the market is categorised into algae-derived alginate, synthetic polymer, polylactide- coglycolide, polyethylene glycol and hydrogels. Final segmentation is based on agent type it is into biologics, cell-based medical devices, and biopharmaceuticals. By geography, the market is predominant in Asia-Pacific, and it continues during the forecast period. North America is in its growing phase and is holding the largest in regenerative medicines market as the therapies are in the 3rd phase of clinical trials.

 Americas Regenerative Medicines Market Trends:

  • Stem cells Inc, a Delaware corporation entered into an agreement and plan of merger and reorganisation with micro bat medical Ltd.
  • Minerva biotechnologies launch alpha STEM, a naïve stem cell culture system.
  • Renova care develops new stem cell device for burn injuries.
  • Mesoblast launches the world’s first off-the-shelf stem cell treatment.

Americas Regenerative Medicines Market Research Report Includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • The principal market players are:
  • Vertex Pharmaceuticals
  • Celgene Corporation
  • Acelity L.P. Inc
  • Stem cells,  Inc
  • Organogenesis Inc

1. Introduction

1.1.   Executive Summary

1.2.   Market Definition

1.3.   The scope of the Study

2. Research Methodology

2.1.   Secondary Research

2.2.   Primary Research

2.3.   Analytics Tools & Model

2.4.   Economic Indicators

2.4.1.Base Year, Base Currency & Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

3. Market Analysis

3.1.   Industry Value Chain Analysis

3.2.   Porter’s Five Force Analysis

3.2.1 Bargaining Power of Suppliers

3.2.2 Bargaining Power of Buyers

3.2.3 Threat of Substitutes

3.2.4 Threat of New Entrants

3.2.5 Industry Rivalry (Competitive Environment)

3.3. PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4. SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.4.5 Y-O-Y Analysis

4. Market Dynamics   

4.1. Drivers

4.1.1 Increase in corporate partnerships to accelerate development and commercialise of regenerative medicine.

4.1.2 Increase in global healthcare expenditure.

4.1.3 Rapid growth in ageing population.

4.1.4. Prevalence of chronic diseases and genetic disorders.

4.2. Restraints

4.2.1 Cost of treatment.

4.2.2 Complex regeneration process.

4.2.3. Lack of guidelines.

4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.

4.3. Opportunities

4.3.1. Strong product pipeline.

4.3.2. The great demand for organ transplantation.

4.4. Challenges

4.4.1 Stringent regulatory policies about stem cell technologies.

5. Americas Regenerative Medicine Market – By Product

5.1 Introduction

5.2 Cell-based products

5.2.1 Allogeneic products

5.2.2 Autologous products

5.3 Acellular products

6. Americas Regenerative Medicine Market – By Application

6.1 Introduction

6.2 Orthopaedic and musculoskeletal disorders

6.3 Dermatology

6.4 Cardiology

6.5 Central nervous system diseases

6.6 Oncology

6.7 Diabetes

6.8 Bone graft substitutes

6.9 Others

7. Americas Regenerative Medicine Market – By Therapy

7.1 Introduction

7.2 Cell therapy

7.3 Immunotherapy

7.4 Tissue therapy

7.5 Gene therapy

7.6 Others

8. Americas Regenerative Medicine Market – By Material

8.1 Introduction

8.2 Algae-derived alginate

8.3 Synthetic polymer

8.4 Poly-lactide-coglycolide

8.5 Poly-ethylene glycol

8.6 Hydrogels

8.7 Others

9. Americas Regenerative Medicine Market – by Agent type

9.1 Introduction

9.2 Biologics

9.2.1 Autologous fibroblasts

9.2.2 Hematopoietic stem and progenitor cells

9.3 Cell-based medical devices

9.3.1 Allogenic fibroblasts

9.3.2 Cell extraction

9.4 Biopharmaceuticals

9.4.1 Tricalcium phosphate

9.4.2 Osteogenic protein

10. Americas Regenerative Medicine Market – By Geography

10.1 Americas

10.1.1 U.S.

10.1.2 Canada

10.1.3 Mexico

10.1.4 Brazil

10.1.5 Argentina

10.1.6. Others

11. Americas Regenerative Medicine Market – Company Profiles

11.1 Celgene Corporation

11.2 Vertex pharmaceuticals

11.3 Acelity L.P. Inc

11.4 Stem cells,  Inc.

11.5 Organogenesis Inc

11.6 Nuvasive Inc

11.7 Mesoblast Ltd

11.8 Advantagene Inc

11.9 Vertical corporation

11.10 Cytori therapeutics

12. Americas Regenerative Medicine Market – Competitive Landscape

12.1 Market Share Analysis

12.2 Strategies Adopted by top companies

12.3 Merges, Acquisitions, Collaborations & Agreements

13. Market Insights

13.1 Industry Experts Insights

13.2 Analysts Opinions

13.3 Investment Opportunities

14. Appendix

14.1 List of tables

14.2 List of figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.